Mechanisms of escape from trastuzumab-mediated ADCC in esophageal squamous cell carcinoma.
食管鳞状细胞癌中曲妥珠单抗介导的 ADCC 的逃逸机制。
基本信息
- 批准号:20790947
- 负责人:
- 金额:$ 2.75万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Young Scientists (B)
- 财政年份:2008
- 资助国家:日本
- 起止时间:2008 至 2009
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We elucidated the mechanisms of escape from trastuzumab-mediated ADCC using esophageal squamous cell carcinoma cell clones. The ADCC assay with purified NK cells showed significantly susceptibility to trastuzumab-mediated ADCC in tumor cell clones. These results indicated that the sensitivity to trastuzumab-mediated ADCC was mainly due to the difference in susceptibility to NK cell-mediated ADCC. Furthermore, the degree of permeabilization induced by PFN and apoptosis induced by the combination of PFN with GrB in tumor cell clones was analyzed. As a result, lower sensitivity for PFN/GrB on tumor clones was related to the reduced trastuzumab-mediated ADCC. In conclusion, lower susceptibility to the perforin-granzyme system is one of the important mechanisms explaining escape from trastuzumab-mediated ADCC.
我们使用食管鳞状细胞癌细胞克隆阐明了逃避曲妥珠单抗介导的ADCC的机制。纯化NK细胞的ADCC试验显示肿瘤细胞克隆对曲妥珠单抗介导的ADCC具有显著敏感性。这些结果表明,对曲妥珠单抗介导的ADCC的敏感性主要是由于对NK细胞介导的ADCC的敏感性差异。此外,分析PFN诱导的透化程度和PFN与GrB组合诱导的肿瘤细胞克隆的凋亡。因此,PFN/GrB对肿瘤克隆的敏感性较低与曲妥珠单抗介导的ADCC降低有关。总之,对穿孔素-颗粒酶系统的敏感性降低是解释曲妥珠单抗介导的ADCC逃逸的重要机制之一。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mechanisms of escape from trastuzumab-mediated ADCC in esophageal squamorscell carcinoma.
食管鳞状细胞癌中曲妥珠单抗介导的 ADCC 的逃逸机制。
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Kono K;Mizukami Y;Daigo Y;Takano A;Masuda K;Yoshida K;Tsunoda T;Kawaguchi Y;Nakamura Y;Fujii H;Yoshihiko Kawaguchi
- 通讯作者:Yoshihiko Kawaguchi
Protein-bound polysaccharide K (PSK) partially prevents apoptosis of circulating T cells induced by anti-cancer drug S-1 in patients with gastric cancer
蛋白结合多糖 K (PSK) 部分阻止胃癌患者抗癌药物 S-1 诱导的循环 T 细胞凋亡
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Mizukami Y;Kono K;Kawaguchi Y;Akaike H;Kamimura K;Sugai H;Fujii H;Yoshiki Mizukami;Koji Kono
- 通讯作者:Koji Kono
Localization Pattern of Foxp3^+ Regulatory T cells is associated with Clinical Behavior in Gastric Cancer
Foxp3^ 调节性 T 细胞的定位模式与胃癌的临床行为相关
- DOI:
- 发表时间:2008
- 期刊:
- 影响因子:0
- 作者:Mizukami Y;Kono K;Kawaguchi Y;Akaike H;Kamimura K;Sugai H;Fujii H;Yoshiki Mizukami;Koji Kono;Yoshiki Mizukami;Yosihki Mizukami
- 通讯作者:Yosihki Mizukami
Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma.
- DOI:10.1038/sj.bjc.6604715
- 发表时间:2008-11-04
- 期刊:
- 影响因子:8.8
- 作者:Mizukami Y;Kono K;Maruyama T;Watanabe M;Kawaguchi Y;Kamimura K;Fujii H
- 通讯作者:Fujii H
Protein-Bound Polysaccharide K Partially Prevents Apoptosis of Circulating T Cells Induced by Anti-Cancer Drug S-1 in Patients with Gastric Cancer
- DOI:10.1159/000151361
- 发表时间:2008-08
- 期刊:
- 影响因子:3.5
- 作者:K. Kono;Y. Kawaguchi;Y. Mizukami;K. Mimura;H. Sugai;H. Akaike;H. Fujii
- 通讯作者:K. Kono;Y. Kawaguchi;Y. Mizukami;K. Mimura;H. Sugai;H. Akaike;H. Fujii
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAWAGUCHI Yoshihiko其他文献
KAWAGUCHI Yoshihiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAWAGUCHI Yoshihiko', 18)}}的其他基金
Local self-governance in modern Japan --- legal history of the relationship between an administrative village and hamlets
近代日本的地方自治——行政村与小村关系的法制史
- 批准号:
18H00792 - 财政年份:2018
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of the anti-HER3 antibody therapy for esophageal squamous cell carcinoma.
食管鳞状细胞癌抗HER3抗体疗法的开发。
- 批准号:
24591936 - 财政年份:2012
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of escape from trastuzumab-mediated ADCC in esophageal squamous cell carcinoma.
食管鳞状细胞癌中曲妥珠单抗介导的 ADCC 的逃逸机制。
- 批准号:
22791268 - 财政年份:2010
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The Formation and Transformation of Modern Land-ownership Structure in Japan?The Legal History of Land and "Mura(Village)"
日本近代土地所有制结构的形成与变迁?土地法制史与“村”
- 批准号:
21530013 - 财政年份:2009
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Legal history of "conciliation" in comparison
“调解”的法律历史比较
- 批准号:
18330004 - 财政年份:2006
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A study of law historical study of Agricultural Land Law
农地法的法史研究
- 批准号:
15530013 - 财政年份:2003
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study of Agricultural Land Iaw in legal history
法制史上农地法研究
- 批准号:
12620012 - 财政年份:2000
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Targeted Anchoring Ecto-enzyme on Cancer Cell Surface to Enhance Antibody Therapy in Breast Cancer
靶向锚定癌细胞表面的胞外酶以增强乳腺癌的抗体治疗
- 批准号:
10353727 - 财政年份:2021
- 资助金额:
$ 2.75万 - 项目类别:
Targeted Anchoring Ecto-enzyme on Cancer Cell Surface to Enhance Antibody Therapy in Breast Cancer
靶向锚定癌细胞表面的胞外酶以增强乳腺癌的抗体治疗
- 批准号:
10539331 - 财政年份:2021
- 资助金额:
$ 2.75万 - 项目类别:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
使用第二种 NK 激活抗体增强肿瘤靶向抗体治疗。
- 批准号:
8111155 - 财政年份:2010
- 资助金额:
$ 2.75万 - 项目类别:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
使用第二种 NK 激活抗体增强肿瘤靶向抗体治疗。
- 批准号:
8465200 - 财政年份:2010
- 资助金额:
$ 2.75万 - 项目类别:
Enhancing tumor-targeted antibody therapy with a second NK activating antibody.
使用第二种 NK 激活抗体增强肿瘤靶向抗体治疗。
- 批准号:
8265662 - 财政年份:2010
- 资助金额:
$ 2.75万 - 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
- 批准号:
7313944 - 财政年份:2007
- 资助金额:
$ 2.75万 - 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
- 批准号:
8325703 - 财政年份:2002
- 资助金额:
$ 2.75万 - 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
- 批准号:
7916683 - 财政年份:2002
- 资助金额:
$ 2.75万 - 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
- 批准号:
8139925 - 财政年份:2002
- 资助金额:
$ 2.75万 - 项目类别:
ANTIBODY THERAPY FOR BREAST CANCER: INVESTIGATION OF IMMUNE MODULATION WITH IL-21
乳腺癌抗体治疗:IL-21 免疫调节研究
- 批准号:
7682171 - 财政年份:2002
- 资助金额:
$ 2.75万 - 项目类别:














{{item.name}}会员




